Building a gene editing lexicon: a model for rare and inherited disorders. [PDF]
Valentino LA +9 more
europepmc +1 more source
Access in all areas? A round-up of developments in market access and health technology assessment: first Joint Clinical Assessment report released. [PDF]
Ramagopalan SV, Pannelay AJ.
europepmc +1 more source
Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands. [PDF]
Gort J +6 more
europepmc +1 more source
Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential. [PDF]
Viprakasit V +3 more
europepmc +1 more source
Designs of the clinical trials aiming at evaluating cell and gene therapy products: A critical appraisal from a literature review. [PDF]
Biard L +3 more
europepmc +1 more source
Advanced therapies and cancer policy in Latin America: why regulatory coherence matters more than technological capacity. [PDF]
Silva-Moreno E.
europepmc +1 more source
Editorial: Clinical translation and commercialisation of advanced therapy medicinal products, volume II. [PDF]
Bayon Y, Vertès AA.
europepmc +1 more source
The polymeric nanovectors landscape for cancer immunotherapies towards advanced therapy medicinal products (ATMPs). [PDF]
Palamà IE +12 more
europepmc +1 more source
Regulatory Convergence in Cell and Gene Therapy: Harmonizing Quality, CMC, and Approval Pathways Across the FDA, EMA, PMDA, and Emerging Markets. [PDF]
Verma N, Arora S.
europepmc +1 more source
A decade of innovation in healthcare: Automation, bio-printing and digital twin technologies for personalized therapies. [PDF]
Ghavami D +3 more
europepmc +1 more source

